Loading insider details...
Beta
Latest Form 4 (Jun 15, 2026): Grant/Award of 4,666 DFTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 4,666 | n/a |
| May 21, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 4,000 | n/a |
| Jun 16, 2025 | Mind Medicine (MindMed) Inc. (MNMD) | Grant/Award | 75,187 | n/a |
| Jun 10, 2025 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 30,000 | n/a |
| May 16, 2025 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 6,500 | n/a |
| Jun 18, 2024 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 26,764 | n/a |
| Jun 12, 2024 | Mind Medicine (MindMed) Inc. (MNMD) | Grant/Award | 16,506 | n/a |
| Jun 7, 2024 | Vigil Neuroscience, Inc. (VIGL) | Grant/Award | 18,068 | n/a |
| May 10, 2024 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 6,500 | n/a |
| May 7, 2024 | Vigil Neuroscience, Inc. (VIGL) | Disposition to Issuer | 24,310 | n/a |